Biopharma Business Check – Financing and Review (Pharmaceutical Executive, February 2025)Jonathan Choi2025-02-17T18:02:53+00:00February 7th, 2025|Featured, Our Publications|
Global M&A Treads WaterJonathan Choi2025-02-17T17:56:46+00:00February 7th, 2025|Featured, Our Publications|
Divestitures in the Current EnvironmentJonathan Choi2025-02-05T22:23:10+00:00January 28th, 2025|Featured, Our Publications|
Reflections on 2024 and Outlook – Stock Market and FundingJonathan Choi2025-02-05T22:13:34+00:00January 28th, 2025|Featured, Our Publications|
Reflections on 2024 and Outlook – Senior Management Approach to M&AJonathan Choi2025-02-05T22:09:34+00:00January 28th, 2025|Featured, Our Publications|
Reflections on 2024 and Outlook – Biotech and Pharma M&AJonathan Choi2025-02-05T22:03:00+00:00January 28th, 2025|Featured, Our Publications|
2024 Chemical Conference Speaker SummaryJonathan Choi2024-12-06T22:11:15+00:00November 13th, 2024|Chemical Conferences|
Young & Partners 2024 Chemical Conference: Speakers Roundtable- What Does the Future Hold?Jonathan Choi2025-01-02T19:25:19+00:00November 13th, 2024|Our Broadcasts|
Young & Partners 2024 Chemical Conference: Dewey Johnson: Global Energy & Chemical Markets – Emerging from the TroughJonathan Choi2025-01-02T19:22:42+00:00November 13th, 2024|Our Broadcasts|
Young & Partners 2024 Chemical Conference: Perspectives on Asia and the Middle East and the Impact on ChemicalsJonathan Choi2025-01-02T19:21:02+00:00November 13th, 2024|Our Broadcasts|
